Literature DB >> 9027589

Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro.

N Jaiswal1, S E Haynesworth, A I Caplan, S P Bruder.   

Abstract

Human bone marrow contains a population of cells capable of differentiating along multiple mesenchymal cell lineages. Recently, techniques for the purification and culture-expansion of these human marrow-derived Mesenchymal Stem Cells (MSCs) have been developed. The goals of the current study were to establish a reproducible system for the in vitro osteogenic differentiation of human MSCs, and to characterize the effect of changes in the microenvironment upon the process. MSCs derived from 2nd or 3rd passage were cultured for 16 days in various base media containing 1 to 1000 nM dexamethasone (Dex), 0.01 to 4 mM L-ascorbic acid-2-phosphate (AsAP) or 0.25 mM ascorbic acid, and 1 to 10 mM beta-glycerophosphate (beta GP). Optimal osteogenic differentiation, as determined by osteoblastic morphology, expression of alkaline phosphatase (APase), reactivity with anti-osteogenic cell surface monoclonal antibodies, modulation of osteocalcin mRNA production, and the formation of a mineralized extracellular matrix containing hydroxyapatite was achieved with DMEM base medium plus 100 nM Dex, 0.05 mM AsAP, and 10 mM beta GP. The formation of a continuously interconnected network of APase-positive cells and mineralized matrix supports the characterization of this progenitor population as homogeneous. While higher initial seeding densities did not affect cell number of APase activity, significantly more mineral was deposited in these cultures, suggesting that events which occur early in the differentiation process are linked to end-stage phenotypic expression. Furthermore, cultures allowed to concentrate their soluble products in the media produced more mineralized matrix, thereby implying a role for autocrine or paracrine factors synthesized by human MSCs undergoing osteoblastic lineage progression. This culture system is responsive to subtle manipulations including the basal nutrient medium, dose of physiologic supplements, cell seeding density, and volume of tissue culture medium. Cultured human MSCs provide a useful model for evaluating the multiple factors responsible for the step-wise progression of cells from undifferentiated precursors to secretory osteoblasts, and eventually terminally differentiated osteocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9027589

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  450 in total

1.  Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy.

Authors:  Z Hou; Q Nguyen; B Frenkel; S K Nilsson; M Milne; A J van Wijnen; J L Stein; P Quesenberry; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Differentiation of human mesenchymal stem cells on niobium-doped fluorapatite glass-ceramics.

Authors:  Meenakshi Kushwaha; Xueliang Pan; Julie A Holloway; Isabelle L Denry
Journal:  Dent Mater       Date:  2011-11-09       Impact factor: 5.304

3.  Biphasic peptide amphiphile nanomatrix embedded with hydroxyapatite nanoparticles for stimulated osteoinductive response.

Authors:  Joel M Anderson; Jessica L Patterson; Jeremy B Vines; Amjad Javed; Shawn R Gilbert; Ho-Wook Jun
Journal:  ACS Nano       Date:  2011-11-17       Impact factor: 15.881

4.  Immunomodulation of tissue-engineered transplants: in vivo bone generation from methylprednisolone-stimulated chondrocytes.

Authors:  Andreas Haisch; Frank Wanjura; Cornelia Radke; Korinna Leder-Jöhrens; Andreas Gröger; Michaela Endres; Svea Klaering; Alexander Loch; Michael Sittinger
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-25       Impact factor: 2.503

5.  Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1.

Authors:  M Emura; A Ochiai; M Horino; W Arndt; K Kamino; S Hirohashi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

6.  In vivo bone formation by human bone marrow cells: effect of osteogenic culture supplements and cell densities.

Authors:  S C Mendes; I Van Den Brink; J D De Bruijn; C A Van Blitterswijk
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

7.  Mesenchymal stem cells combined with biphasic calcium phosphate ceramics promote bone regeneration.

Authors:  T L Livingston; S Gordon; M Archambault; S Kadiyala; K McIntosh; A Smith; S J Peter
Journal:  J Mater Sci Mater Med       Date:  2003-03       Impact factor: 3.896

8.  From design of bio-based biocomposite electrospun scaffolds to osteogenic differentiation of human mesenchymal stromal cells.

Authors:  Julien Ramier; Daniel Grande; Thibault Bouderlique; Olya Stoilova; Nevena Manolova; Iliya Rashkov; Valérie Langlois; Patricia Albanese; Estelle Renard
Journal:  J Mater Sci Mater Med       Date:  2014-03-02       Impact factor: 3.896

9.  Square prism micropillars improve osteogenicity of poly(methyl methacrylate) surfaces.

Authors:  O Hasturk; M Ermis; U Demirci; N Hasirci; V Hasirci
Journal:  J Mater Sci Mater Med       Date:  2018-05-02       Impact factor: 3.896

10.  Effect of scaffold microarchitecture on osteogenic differentiation of human mesenchymal stem cells.

Authors:  Ameya Phadke; YongSung Hwang; Su Hee Kim; Soo Hyun Kim; Tomonori Yamaguchi; Koichi Masuda; Shyni Varghese
Journal:  Eur Cell Mater       Date:  2013-01-18       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.